Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group

Cerebrovascular Diseases

Abstract

Although a considerable body of scientific data is now available on neuroprotection in acute ischaemic stroke, this field is not yet established in clinical practice. At its third meeting, the European Ad Hoc Consensus Group considered the potential for neuroprotection in acute stroke and the practical problems attendant on the existence of a very limited therapeutic window before irreversible brain damage occurs, and came to the following conclusions. NEUROPROTECTANTS IN CLINICAL DEVELOPMENT: Convincing clinical evidence for an efficacious neuroprotective treatment in acute stroke is still required. Caution should be exercised in interpreting and extrapolating experimental results to stroke patients, who are a very heterogeneous group. The limitations of the time windows and the outcome measures chosen in trials of acute stroke therapy have an important influence on the results. The overall distribution of functional outcomes provides more statistical information than the proportion above a threshold outcome value. Neurological outcome should also be assessed. Neuroprotectants should not be tested clinically in phase II or phase III trials in a time window that exceeds those determined in experimental studies. The harmful effe...Continue Reading

Citations

Nov 4, 2000·Expert Opinion on Investigational Drugs·K K Jain
Jul 21, 2001·CNS Drugs·D S Liebeskind, S E Kasner
Oct 6, 2001·Stroke; a Journal of Cerebral Circulation·J HornM Limburg
Mar 29, 2008·Stroke; a Journal of Cerebral Circulation·Maria Luisa Sacchetti
Dec 25, 2008·Circulation·Mark J AlbertsUNKNOWN American Heart Association Writing Group 4
Feb 28, 2013·Stroke; a Journal of Cerebral Circulation·Robbert-Jan Van HooffRaf Brouns
Jul 2, 1999·Stroke; a Journal of Cerebral Circulation·W D HeissR Graf
Sep 7, 2000·The New England Journal of Medicine·T Brott, J Bogousslavsky
Oct 28, 1999·Current Opinion in Ophthalmology·N N OsborneJ P Wood
Sep 24, 2011·Stroke Research and Treatment·Zahra-Nadia SharifiGholamreza Hassanzadeh
Feb 2, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Victoria E O'CollinsDavid W Howells
Oct 3, 2006·Current Opinion in Anaesthesiology·D K Menon, A C Summors
Mar 24, 2006·Pharmacotherapy·Hazem F ElewaSusan C Fagan
May 17, 2003·Stroke; a Journal of Cerebral Circulation·Marc Fisher, UNKNOWN Stroke Therapy Academic Industry Roundtable
Oct 28, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Victoria E O'CollinsDavid W Howells
Apr 22, 2017·The Cochrane Database of Systematic Reviews·Liliya Eugenevna ZiganshinaLudivine Vernay
Jul 15, 2020·The Cochrane Database of Systematic Reviews·Liliya Eugenevna ZiganshinaCharles Hv Hoyle
Sep 2, 1999·Stroke; a Journal of Cerebral Circulation·R Schmid-ElsaesserH J Reulen
Oct 9, 2002·Current Medical Research and Opinion·Hans-Christoph Diener, Thomas C Wessel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna
A M BasileD Inzitari
Ideggyógyászati szemle
Zsolt ZádorTibor Hortobágyi
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Y Suzuki, K Umemura
© 2022 Meta ULC. All rights reserved